Gene Therapy- ASGCT Conference Coverage 2023

Our analyst team screened the abstracts presented at the 2023 American Society of Cell & Gene Therapy (ASGCT) Annual Meeting and identified 189 abstracts (34 clinical and 155 preclinical) relevant to gene editing therapies. We expect our conference coverage documents helped you plan your time effectively and stay updated with relevant and exciting developments within gene therapies. As part of our ASGCT Conference Coverage set, the post-conference analysis report can be viewed below.

Post-Conference Report

This post-conference report offers a complete guide to all the Gene Therapy topics and provides analysis and a summary of abstracts. Most of the presented data at the ASGCT Annual Meeting showcased preclinical data.

Download Now

Pre-Conference Planner

This pre-conference planner lists abstracts in order of presentation, categorized separately by clinical trial data and preclinical drug data. We hope you find this pre-conference helpful planner and insightful and are as excited as us to see the latest developments in the Gene Therapy field.

Download Now

More Resources

Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.

With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.

Discover a database tailored to your needs